How will ASCO combat cancer disparities?

CD-19 mutation frequency after blinatumomab treatment is lower than after CAR T-cell therapy

Controlling CRS-related coagulopathy improves the safety of CAR T-cell therapy for MM

ICARIA results: Treating RRMM patients with isatuximab, pomalidomide and low-dose dexamethasone

HORIZON update: Using melflufen to treat RRMM patients refractory to daratumumab and/or pomalidomide

The changing landscape of AML

Cancer care in low and middle income countries

Cancer care in Latin America

Surveying cancer patients' mental health and financial problems

Implementing better cancer diagnosis in low and middle income countries

Project Pink Blue: Fighting cancer through increasing awareness, screening, advocacy and patient navigation

Challenges in global cancer control